Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bioanalytical services. The company specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. The company focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identified up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.
Follow-Up Questions
PIQLF の株価パフォーマンスは？
PIQLF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Proteomics International Laboratories Ltd の主な事業テーマや業界は？
Proteomics International Laboratories Ltd は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
Proteomics International Laboratories Ltd の時価総額はいくらですか？
Proteomics International Laboratories Ltd の現在の時価総額は $0 です。
Proteomics International Laboratories Ltd は、買い、売り、ホールドのどれですか？
